These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 30391771)
1. Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases. Della Puppa A; Munari M; Gardiman MP; Volpin F World Neurosurg; 2019 Feb; 122():e856-e863. PubMed ID: 30391771 [TBL] [Abstract][Full Text] [Related]
2. Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium. Yano H; Nakayama N; Ohe N; Miwa K; Shinoda J; Iwama T J Neurooncol; 2017 Jun; 133(2):389-397. PubMed ID: 28432590 [TBL] [Abstract][Full Text] [Related]
3. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781 [TBL] [Abstract][Full Text] [Related]
4. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas. Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783 [TBL] [Abstract][Full Text] [Related]
6. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme. Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505 [TBL] [Abstract][Full Text] [Related]
7. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888 [TBL] [Abstract][Full Text] [Related]
8. A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA-Induced Fluorescence in High-Grade Gliomas. Vogelbaum MA; Kroll D; Etame A; Tran N; Liu J; Ford A; Sparr E; Kim Y; Forsyth P; Sahebjam S; Mokhtari S; Peguero E; Macaulay R World Neurosurg; 2021 May; 149():e498-e503. PubMed ID: 33561551 [TBL] [Abstract][Full Text] [Related]
9. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma. Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K- Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871 [TBL] [Abstract][Full Text] [Related]
10. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387 [TBL] [Abstract][Full Text] [Related]
11. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment. Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256 [TBL] [Abstract][Full Text] [Related]
13. The use of the YELLOW 560 nm surgical microscope filter for sodium fluorescein-guided resection of brain tumors: Our preliminary results in a series of 28 patients. Hamamcıoğlu MK; Akçakaya MO; Göker B; Kasımcan MÖ; Kırış T Clin Neurol Neurosurg; 2016 Apr; 143():39-45. PubMed ID: 26895208 [TBL] [Abstract][Full Text] [Related]
14. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients. Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770 [TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of low-dose fluorescein-guided resection of glioblastoma. Fan C; Jiang Y; Liu R; Wu G; Wu G; Xu K; Miao Z Clin Neurol Neurosurg; 2018 Dec; 175():57-60. PubMed ID: 30384117 [TBL] [Abstract][Full Text] [Related]
16. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129 [TBL] [Abstract][Full Text] [Related]
17. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival. Coburger J; Hagel V; Wirtz CR; König R PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409 [TBL] [Abstract][Full Text] [Related]
18. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma. Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971 [TBL] [Abstract][Full Text] [Related]